Zhenling Li

5PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 17, 2026
Comparative efficacy and safety of systemic therapies in transplant-eligible and ineligible relapsed/refractory large B-cell lymphoma: a Bayesian network meta-analysis.

|Jun 01, 2021
MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes.

Chao Guo, Ya-Yue Gao, Qian-Qian Ju

|May 30, 2021
The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AML.

Chao Guo, Ya-Yue Gao, Qian-Qian Ju

|Jan 24, 2021
HELQ and EGR3 expression correlate with IGHV mutation status and prognosis in chronic lymphocytic leukemia.

Chao Guo, Ya-Yue Gao, Qian-Qian Ju

|Sep 05, 2020
LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.

Chao Guo, Ya-Yue Gao, Qian-Qian Ju

Pageof 1

Frequent Collaborators

1 joint publications

Liling Huang